期刊文献+

早期脓毒症患者血清基质金属蛋白酶测定及其临床意义 被引量:3

Clinical significance of the concentrations of MMP - 9 in serum of patients with early sepsis
下载PDF
导出
摘要 目的 探讨血清基质金属蛋白酶(MMP-9)水平在早期(sepsis)脓毒症患者诊断的参考价值和预后判断意义。方法根据脓毒症及全身炎症反应综合征(SIRS)诊断标准,依据104例重症患者24h病情变化,分成三组:A组(sepsis组)44例;B组(SIRS组)36例;C组(非SIRS组)24例。检测患者转人ICU后2h内血清MMP-9浓度及各项临床指标,探讨其与病情严重程度间相关性,并对影响患者病情严重程度的危险因素进行回归分析。结果①A、B、C组患者MMP-9平均水平依次为(6.46±0.58)mg/L、(6.01±0.71)mg/L、(5.22±0.73)mg/L,组间差异均有统计学意义(P〈0.01)。②相关性分析显示,患者MMP-9水平与APACHEⅡ评分、SOFA评分存在正相关(P〈0.01)。③多元有序Logistic回归显示MMP-9指标进入回归方程(P〈0.01)。④ROC分析显示,MMP-9水平对判定重症患者早期脓毒症发生与否的曲线下面积达0.780(P〈0.01)。结论重症患者血清MMP-9水平测定对于脓毒症发生的早期识别、判断具有一定的临床价值,提示MMP-9可能在脓毒症的发生发展过程中起着重要作用。 Objective To study the clinical significance of the concentrations of MMP -9 in serum of patients with early sepsis. Methods 104 critical ills were admited in ICU during 2010.6 to 2011. 2. According to criterias of Sepsis/SIRS, the patients were divided into three groups: group A, sepsis, 44 cases; group B, SIRS, 36 cases; group C, non - SIRS, 24 cases. The MMP -9 in serum of patients was measured during 2 h adimission in ICU. The disease severity within 24 hours was statistically analysed. Results ①The average level of MMP - 9 in group A, B, C were (6.46±0. 53) mg/L, (6.01± 0.71 )mg/L, (5.22 ±0.73 )mg/L respectively and they were significantly different (P 〈0.01 ). ②Correlation analysis showed that MMP- 9 levels in patients were connected with the scores of APACHE Ⅱ and SOFA (P 〈 0.01 ). ③Ordered Multiple Logistic Regression on disease severity showed that MMP-9 indicator was into the regression equation (P 〈0.01 ). ④ROC analysis showed that early MMP -9 levels of patients were helpful to determine the occurrence of sepsis and the area under the curve which was 0. 780 (P 〈 0.01 ). Conclusion The measurement of MMP - 9 was helpful in the identification of early sepsis and to determine disease severity of critically ills. MMP - 9 may make significant impact on the pathological process of sepsis.
出处 《中国急救医学》 CAS CSCD 北大核心 2011年第12期1072-1075,共4页 Chinese Journal of Critical Care Medicine
关键词 基质金属蛋白酶 脓毒症 全身炎症反应综合征 APACHEU评分 Matrix metalloproteinases - 9 Sepsis Systemic inflammatory response syndrome APACHE Ⅱscore
  • 相关文献

参考文献7

二级参考文献10

  • 1Kinasewitz GT, Yan SB, Basson B,et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ J ]. Crit Care, 2004,8 ( 2 ) : R82 - R90. 被引量:1
  • 2Arts DG,de Keizer NF,Vroom MB,et al. Reliability and accuracy of sequential organ failure assessment ( SOFA ) scoring [ J ]. Crit Care Med,2005,33 ( 9 ) : 1988 - 1993. 被引量:1
  • 3Mitchell M, Mitchell P, John C ,et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference [ J ]. Int Care Med ,2003,29:530 - 538. 被引量:1
  • 4Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units:results of a muhicenter, prospective study [ J ]. Crit Care Med, 1998,26( 11 ) : 1793 - 1880. 被引量:1
  • 5Amaral A, Opal SM, Vincent JL. Coagulation in sepsis [ J ]. Int Care Med,2004 ,30 (6) : 1032 - 1040. 被引量:1
  • 6Cando S,Nanzaki S,Sasaki S,et al. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock [ J ]. Crit Care Med, 1998,26:2005 - 2009. 被引量:1
  • 7Moreno R, Vincent JL, Matos R, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care:results of a prospective, muhicentre study [ J ]. Int Care Med, 1999,25 (7) :686 -696. 被引量:1
  • 8Maria MA, Pena JM, Fernandez A, et al. Time course and prognostic significant of hemostatic changes in sepsis: relation to tumor necrosis factor-α [ J ]. Crit Care Med, 1999,27 : 1303 - 1308. 被引量:1
  • 9Minnema MC, Chang AC, Jansen PM, et al. Recombinant human antithrombin Ⅲ improves survival and attenuates inflammatory responses in baboons lethally challenged with Eschcrichia coli [ J ]. Blood,2000,95 (4) :1117 - 1123. 被引量:1
  • 10Warren BL, Eid A,Singer P, et al. High dose antithrombin Ⅲ in severe sepsis: a randomized controlled trial [ J ]. JAMA, 2001 , 286 : 1869 - 1878. 被引量:1

共引文献16

同被引文献40

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部